Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial

James Chih Hsin Yang, D. Ross Camidge, Cheng Ta Yang, Jianying Zhou, Renhua Guo, Chao Hua Chiu, Gee Chen Chang, Her Shyong Shiah, Yuan Chen, Chin Chou Wang, David Berz, Wu Chou Su, Nong Yang, Ziping Wang, Jian Fang, Jianhua Chen, Petros Nikolinakos, You Lu, Hongming Pan, Ajit ManiamLyudmila Bazhenova, Keisuke Shirai, Mohammad Jahanzeb, Maurice Willis, Nehal Masood, Naveed Chowhan, Te Chun Hsia, Hong Jian, Shun Lu

Research output: Contribution to journal › Article › peer-review

120 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science